EVAXEvaxion Biotech A/S

3.310USDMkt Cap: 27.61M $P/E:

Evaxion A/S, a clinical-stage biotech company, develops artificial intelligence-powered immunology vaccines. The company develops EVX-01, which is in phase 2 global multi-center clinical trial for the treatment of advanc…

Key Statistics

Company
Market Cap27.61M $
Enterprise Value17.79M $
Revenue (TTM)7.49M $
Gross Profit7.49M $
Net Income (TTM)-7.71M $
Revenue/Share0.9420 USD
Last Price3.310 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees46
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN
Valuation
P/E (Trailing)
P/E (Forward)-220.67
PEG
EV/EBITDA-2.14
EV/Revenue2.37
P/S3.69
P/B2.09
EPS (TTM)-1.00
EPS (Forward)-0.01
52W Range
3.12058% of range3.450
52W High3.450 USD
52W Low3.120 USD
Profitability
Gross Margin100.00%
Oper. Margin-116.02%
EBITDA Margin-111.15%
Profit Margin-102.38%
ROE-45.23%
ROA-27.13%
Growth
Revenue Growth
Earnings Growth
Cash Flow & Leverage
Operating CF-6.63M $
CapEx (TTM)11.00K $
FCF Margin-68.55%
FCF Yield-18.60%
Net Debt-6.89M $
Net Debt/EBITDA0.83
Balance Sheet
Debt/Equity0.44
Current Ratio5.06
Quick Ratio4.74
Book Value/Sh1.584 USD
Cash/Share1.877 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Splits
Last Split1:5
Split DateJan 14, 2025
Analyst Consensus
Rating1.3 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)11.25 USD
Upside (mean)+239.9%
Target Range9.000 USD16.00 USD
$9.000+239.9% to mean$16.00
# Analysts4
Ownership
Shares Out.8.34M
Float5.08M
Insiders17.47%
Institutions10.05%
Short Interest
Short Ratio1.1d
Short % Float0.24%
Short % Out.0.20%
Shares Short16.82K
Short (prev mo.)29.39K
Technical
SMA 503.147 (+5.2%)
SMA 2004.061 (-18.5%)
Beta
S&P 52W Chg19.18%
Avg Vol (30d)538.16K
Avg Vol (10d)1.06M
Technical Indicators
RSI (14)59.8
MACD0.0342
MACD Signal-0.0101
MACD Hist.+0.0443
BB Upper3.385 USD
BB Middle3.037 USD
BB Lower2.689 USD
BB Width22.92%
ATR (14)0.2584 USD
Vol Ratio (20d)1.05x